Skip to content
Screener

ClearPoint Neuro CLPT Q3 2025 earnings

Reported November 6, 2025 · Before market open

Revenue$8.9MMiss by $1.5M
EPS-$0.21Miss by $0.01
Revenue estimate$10.4M
EPS estimate-$0.20

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$12.3M
EPS estimate-$0.31

Financials

Q3 2025

Income statement

See full
Revenue$8.9M+9.1%
Gross profit$5.6M+15.5%
Operating income-$5.3M-2.3%
Net income-$5.9M-18.4%
EPS (diluted)-$0.21-16.7%

Balance sheet

See full
Cash & equivalents$38.4M+78.0%
Total debt$35.7M+868%
Total equity$15.9M-45.3%
Total assets$60.4M+50.2%

Cash flow

See full
Operating cash flow-$3.1M-160%
CapEx$199.0K+1,558%
Free cash flow-$3.3M-174%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$619.43M+100%
Enterprise value$616.78M+112%
P/S18×+7.9×

Profitability

See full
Gross margin61.3%+0.9pp
Operating margin-66.3%+5.2pp
Net margin-67.4%+10.1pp
FCF margin-40.3%+24.2pp

Returns & leverage

See full
Return on equity-103.1%+107pp
Debt / equity2.3×+2.1×
Current ratio6.4×+1.8×

Segments

By product

See full
Biologics And Drug Delivery$4.4M-0.7%
Neurosurgery Navigation And Therapy$3.4M+19.7%
Neurosurgery Navigation And Therapy Disposable Products$3.4M+19.7%
Biologics And Drug Delivery Services And License Fees$3.1M+31.3%
Biologics And Drug Delivery Disposable Products$1.3M-37.3%

FAQ

When did ClearPoint Neuro report Q3 2025 earnings?
ClearPoint Neuro (CLPT) reported Q3 2025 earnings on November 6, 2025 before market open.
What were ClearPoint Neuro's Q3 2025 revenue and EPS?
ClearPoint Neuro reported revenue of $8.9M and eps of $-0.21 for Q3 2025.
Did ClearPoint Neuro beat estimates in Q3 2025?
Revenue missed the consensus estimate of $10.4M by $1.5M. EPS missed the consensus estimate of $-0.20 by $0.01.
How did ClearPoint Neuro's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.1% from $8.1M a year earlier and eps declined 16.7% from $-0.18.
Where can I find ClearPoint Neuro's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-270019) and the 10-Q periodic report (0001193125-25-270123) directly on SEC EDGAR. The filing index links above go to sec.gov.